These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique. Maghsoodi M; Sadeghpoor F Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658 [TBL] [Abstract][Full Text] [Related]
8. Preparation of solid dispersions of nonsteroidal anti-inflammatory drugs with acrylic polymers and studies on mechanisms of drug-polymer interactions. Pignatello R; Ferro M; Puglisi G AAPS PharmSciTech; 2002; 3(2):E10. PubMed ID: 12916947 [TBL] [Abstract][Full Text] [Related]
9. Preparation and physicochemical characterization of naproxen-PLGA nanoparticles. Javadzadeh Y; Ahadi F; Davaran S; Mohammadi G; Sabzevari A; Adibkia K Colloids Surf B Biointerfaces; 2010 Dec; 81(2):498-502. PubMed ID: 20719477 [TBL] [Abstract][Full Text] [Related]
10. Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation. El-Habashy SE; Allam AN; El-Kamel AH Int J Nanomedicine; 2016; 11():2369-80. PubMed ID: 27307735 [TBL] [Abstract][Full Text] [Related]
11. Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery. Katara R; Sachdeva S; Majumdar DK Pharm Dev Technol; 2019 Mar; 24(3):368-379. PubMed ID: 29897843 [TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of piroxicam-HPMCAS solid dispersions for ocular use. Jachowicz R; Czech A Pharm Dev Technol; 2008; 13(6):495-504. PubMed ID: 18720246 [TBL] [Abstract][Full Text] [Related]
13. Enhanced ocular anti-inflammatory activity of ibuprofen carried by an Eudragit RS100 nanoparticle suspension. Bucolo C; Maltese A; Puglisi G; Pignatello R Ophthalmic Res; 2002; 34(5):319-23. PubMed ID: 12381895 [TBL] [Abstract][Full Text] [Related]
14. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying. Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963 [TBL] [Abstract][Full Text] [Related]
15. Fabrication and evaluation of Eudragit Chantasart D; Tocanitchart P; Wongrakpanich A; Teeranachaideekul V; Junyaprasert VB Pharm Dev Technol; 2018 Oct; 23(8):771-779. PubMed ID: 28406344 [TBL] [Abstract][Full Text] [Related]
16. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery. Katara R; Majumdar DK Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566 [TBL] [Abstract][Full Text] [Related]
18. Moxifloxacin loaded nanoparticles of disulfide bridged thiolated chitosan-eudragit RS100 for controlled drug delivery. Iqbal O; Shah S; Abbas G; Rasul A; Hanif M; Ashfaq M; Afzal Z Int J Biol Macromol; 2021 Jul; 182():2087-2096. PubMed ID: 34087298 [TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of nebivolol nanoparticles using Eudragit® RS100. Jana U; Mohanty AK; Manna PK; Mohanta GP Colloids Surf B Biointerfaces; 2014 Jan; 113():269-75. PubMed ID: 24140793 [TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of piroxicam from novel solid lipid microparticles formulated with homolipids from Bos indicus. Nnamani PO; Attama AA; Kenechukwu FC; Ibezim EC; Adikwu MU Curr Drug Deliv; 2013 Dec; 10(6):645-55. PubMed ID: 23140234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]